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CTV News footage of premature lamb developing in Biobag (Partridge et al. 2017).
Introduction
▪ After hysterotomy, extremely premature lamb fetuses have been transferred to an ex vivo 
uterine environment, demonstrating normal development and survival (Partridge 2017; Usuda
et al. 2019).
▪ This offers proof of principle for partial ectogenesis: i.e. transfer of a partially developed 
embryo or fetus to an artificial womb for further development.
Current developments in artificial womb technology have rekindled the expectation that human 
ectogenesis may come within reach. 
Expected applications of human ectogenesis: 
▪ Improve neonatal intensive care; 
▪ Provide an alternative for surrogacy or uterus transplantation; 
▪ Possibility to terminate pregnancy without ending the life of the fetus; 
▪ Remedy gender inequity; 
▪ Advance fetal therapy. 
Ectogenesis could facilitate fetal therapy by enabling prenatal treatment interventions outside 
the body of the pregnant person. 
▪ This paper addresses the morally relevant connection between ectogenesis and the fetus as a 
potential beneficiary of treatment.
▪ Recognition of the fetus as a potential beneficiary of treatment comes with ethical questions 
about how responsibilities towards fetal interests should be balanced against the interests of 
the pregnant person.
▪ The study question of this paper, then, is how artificial womb technology would affect the way 
that obligations towards the future child and obligations towards the expecting mother are 
balanced against each other.
Background
Relational as well as technological factors shape expectations about pregnant women’s 
responsibility for the health of their future child, and this might feed into internal and external 
pressures to undergo interventions for fetal benefit. 
The relevance for ectogenesis lies in the fact that artificial womb technology could become an 
important facilitator in this process.
When it is said that partial ectogenesis could make fetal interventions easier by allowing the 
fetus to be treated outside the pregnant person’s body, it is still of central importance to keep in 
mind that, as is the case for in utero fetal surgery, the fetal transfer to an artificial womb will 
also require an invasive surgical intervention on the woman’s body, probably in the form of a 
Caesarean section.
Results: The ethics of ectogenesis aided fetal 
treatment
▪ This is closely connected to technological developments that provide access to and 
information about the prenatal environment. 
▪ Ever more technologies are becoming available that enable identification of fetal 
abnormalities (e.g. prenatal ultrasound and prenatal genomic diagnosis) and that 
subsequently facilitate intervention (e.g. fetal surgery). 
▪ Not only could ectogenesis facilitate the monitoring of fetal development, it could also 
provide easier access for prenatal interventions aimed at fetal treatment.
▪ Today, in utero fetal treatment risks possible maternal side effects such as surgical 
complications and a risk of rupturing the uterus (Ovaere et al. 2015).
▪ The belief that fetal treatment would be safer if it occurred inside an artificial womb could 
work as a catalyst for developing human ectogenesis. 
▪ The assessment of the invasiveness of procedures like Caesarean sections is rather mixed. On 
the one hand, Caesareans come with known dangers. On the other hand, the increase of 
elective Caesareans (in the absence of medical indications) may create an image of 
Caesareans as minor interventions, which sometimes goes hand in hand with a certain 
minimization of the associated risks. 
▪ It is worthwhile to consider the hypothesis that a minimization of the invasiveness of 
Caesareans might reinforce pressures on pregnant persons to undergo a surgical intervention 
to transfer the fetus to an artificial womb for the benefit of the fetus.
While a pregnant woman may have obligations of beneficence towards the fetus, she may 
nevertheless refuse medical interventions, not only because of the value of autonomy, but also 
because of the value of bodily integrity.
▪ Importantly, dominant guidelines in neonatal care often urge directive counselling to convince 
pregnant persons to undergo medical interventions for the benefit of the fetus, if the fetus is 
viable (Chervenak and McCullough 1997). 
▪ It is of particular relevance in this respect that fetuses that cannot be clinically sustained ex 
utero today may become viable fetuses once artificial womb technology becomes clinically 
available.
▪ This might further reinforce pressures on pregnant women to undergo fetal removal when 
fetal therapy is advocated and possibly open the door for routine directive counselling for fetal 
benefit when ectogenesis-aided fetal treatment becomes possible.
▪ Directive recommendations for fetal benefit should take into account autonomy-related 
interests of pregnant women that could thus be undermined. For many pregnant women, the 
experience of gestating and carrying a fetus in the womb to birth is a central aspect of 
pregnancy.
Conclusion
▪ With the prospect of partial ectogenesis, its effect on fetal viability and the associated 
possibility of treating the fetus outside the female body, there might be an increased tension 
between a clinician’s obligations towards the pregnant woman and his/her duties of 
beneficence towards the future child. 
▪ It is concluded that, even if ectogenesis could make fetal therapy easier, one should remain 
sensitive to the fact that it would not circumvent the key ethical concerns that today 
accompany in utero fetal treatment and that it may even exacerbate potential conflicts 
between directive treatment recommendations and the pregnant woman’s autonomous 
decision to the contrary. 
▪ It is important to inquire whether actual clinical codes of practice are sufficiently fine-grained 
to provide ethical guidance to the future practice of prenatal medicine, taking proper account 
of the pregnant woman’s autonomy.
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